At a glance
ClinicalIndex Comparison RecordN/ACompleted· 66 enrolled
Drug / intervention
CST001device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of the 4th Generation QuantiFERON-TB Test (QFT-Plus) for the Detection of Tuberculosis Infection
In Brief
An observational study evaluating CST001 for Tuberculosis. Completed, enrolled 66 participants across 1 site.
Detailed Summary
To compare the positivity rate of the investigational assay to the currently approved QuantiFERON-TB Gold In-Tube assay.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsTuberculosis
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartOct 2015
Primary CompletionNov 2015
First PostedFeb 2016
Study CompletionMay 2016
TodayJul 2026
First PostedFeb 22, 2016
Enrollment StartOct 27, 2015
Primary CompletionNov 7, 2015
Study CompletionMay 26, 2016
TodayJul 2, 2026
Enrollment to primary: 10 daysPosted 10.4 years ago
Interventions
CST001device